Q: What is Faslodex used for?

Faslodex is used to treat hormone receptor-positive advanced breast cancer .

Q: How does Faslodex work?

How Faslodex Works Faslodex is a type of hormone therapy known as an estrogen receptor antagonist. Many breast cancers are hormone-receptor-positive, which means they use the hormone estrogen to grow and spread. This medication is designed to interfere with that process. The medication works through the following mechanisms: Blocking Receptors: It attaches to estrogen receptors on breast cancer cells. This prevents estrogen from binding to the cells, which cuts off the signals the cancer needs to grow. Downregulation: It also causes the estrogen receptors to break down and be destroyed by the cell. This reduces the overall number of receptors available, making the cells less sensitive to any estrogen remaining in the body. By both blocking and reducing the number of these receptors, the drug helps to slow the progression of advanced breast cancer in people whose tumors are fueled by hormones.

Q: What are the active ingredients in Faslodex?

The active ingredient in Faslodex is fulvestrant .

Q: What are the side effects of Faslodex?

Common side effects of Faslodex may include: injection site pain hot flashes fatigue and others Always consult with a healthcare professional about potential side effects.

Q: What drug class is Faslodex?

Faslodex belongs to the estrogen receptor antagonist drug class.

Q: What is the dosage of Faslodex and how do I take it?

How Faslodex is Administered Faslodex is given as an injection into the muscle of the buttock (intramuscularly). Because of the specific administration requirements, it must be given by a doctor, nurse, or other trained healthcare professional in a medical setting. It is not intended for self-administration. A full dose usually consists of two separate injections, with one administered into each buttock. The healthcare provider will inject the medication slowly to help manage discomfort at the injection site. Dosing Schedule The treatment schedule generally follows a specific pattern to ensure the medication reaches and maintains the correct levels in the body: Initial Phase: When starting treatment, injections are often given more frequently during the first month. Maintenance Phase: After the initial doses, the medication is typically administered once every month for as long as the patient benefits from the treatment. Missed Doses It is important to receive every scheduled injection to ensure the medication works effectively. If an appointment for an injection is missed, contact your healthcare provider right away to reschedule the appointment as soon as possible.

Q: Is Faslodex safe during pregnancy and breastfeeding?

Pregnancy Faslodex can cause harm to a developing fetus. It is important to inform a healthcare provider if you are pregnant or planning to become pregnant before starting this medication. Females who are able to become pregnant should have a pregnancy test to confirm they are not pregnant before starting treatment. Effective birth control should be used during treatment and for one year after the final dose. Males with female partners who can become pregnant should use effective contraception during treatment and for two years after the last dose. Breastfeeding It is not known if Faslodex passes into human breast milk. Due to the potential for serious side effects in a nursing infant, breastfeeding is not recommended during treatment and for one year after the last dose. Discuss feeding options with a healthcare provider if you are currently breastfeeding.

Q: What forms and strengths does Faslodex come in?

Available Forms Faslodex is supplied as a sterile, clear, colorless to yellow, viscous liquid. It is intended for administration by a healthcare professional as an injection into the muscle. The medication is provided in the following format: Pre-filled Syringes: Single-dose glass syringes equipped with a safety needle.

Q: What is the FDA approval status of Faslodex?

FDA Approval Status Faslodex (fulvestrant) was initially approved by the U.S. Food and Drug Administration (FDA) in 2002. It is classified as an estrogen receptor antagonist and is administered as an intramuscular injection. Approved Indications The FDA has approved Faslodex for the treatment of hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced or metastatic breast cancer in the following scenarios: As a single agent for postmenopausal women who have not previously been treated with endocrine therapy. As a single agent for postmenopausal women whose disease has progressed following other endocrine therapy. In combination with palbociclib, abemaciclib, or ribociclib for women whose disease has progressed after endocrine therapy. In combination with abemaciclib as an initial endocrine-based therapy for advanced or metastatic disease. Regulatory Safety Information There are currently no Boxed Warnings or Risk Evaluation and Mitigation Strategies (REMS) required by the FDA for Faslodex. However, regulatory labeling includes warnings regarding embryo-fetal toxicity, advising that the drug can cause harm to a developing fetus. It is also regulated with specific precautions for patients with moderate hepatic (liver) impairment, which may require dose adjustments.

Question 1

What is Faslodex?

Accepted Answer

Faslodex is a medication classified as an estrogen receptor antagonist. It works by binding to estrogen receptors and promoting their degradation, which helps to slow or stop the growth of cells that depend on estrogen to multiply.

This treatment belongs to a class of drugs known as selective estrogen receptor degraders. By reducing the number of estrogen receptors available, the medication interferes with the hormonal signals that drive tumor progression.

Question 2

What is Faslodex used for?

Accepted Answer

Faslodex is used to treat hormone receptor-positive advanced breast cancer.

Question 3

How does Faslodex work?

Accepted Answer

How Faslodex Works

Faslodex is a type of hormone therapy known as an estrogen receptor antagonist. Many breast cancers are hormone-receptor-positive, which means they use the hormone estrogen to grow and spread. This medication is designed to interfere with that process.

The medication works through the following mechanisms:

Blocking Receptors: It attaches to estrogen receptors on breast cancer cells. This prevents estrogen from binding to the cells, which cuts off the signals the cancer needs to grow.
Downregulation: It also causes the estrogen receptors to break down and be destroyed by the cell. This reduces the overall number of receptors available, making the cells less sensitive to any estrogen remaining in the body.

By both blocking and reducing the number of these receptors, the drug helps to slow the progression of advanced breast cancer in people whose tumors are fueled by hormones.

Question 4

What are the active ingredients in Faslodex?

Accepted Answer

The active ingredient in Faslodex is fulvestrant.

Question 5

What are the side effects of Faslodex?

Accepted Answer

Common side effects of Faslodex may include:

injection site pain
hot flashes
fatigue
and others

Always consult with a healthcare professional about potential side effects.

Question 6

What drug class is Faslodex?

Accepted Answer

Faslodex belongs to the estrogen receptor antagonist drug class.

Question 7

What is the dosage of Faslodex and how do I take it?

Accepted Answer

How Faslodex is Administered

Faslodex is given as an injection into the muscle of the buttock (intramuscularly). Because of the specific administration requirements, it must be given by a doctor, nurse, or other trained healthcare professional in a medical setting. It is not intended for self-administration.

A full dose usually consists of two separate injections, with one administered into each buttock. The healthcare provider will inject the medication slowly to help manage discomfort at the injection site.

Dosing Schedule

The treatment schedule generally follows a specific pattern to ensure the medication reaches and maintains the correct levels in the body:

Initial Phase: When starting treatment, injections are often given more frequently during the first month.
Maintenance Phase: After the initial doses, the medication is typically administered once every month for as long as the patient benefits from the treatment.

Missed Doses

It is important to receive every scheduled injection to ensure the medication works effectively. If an appointment for an injection is missed, contact your healthcare provider right away to reschedule the appointment as soon as possible.

Question 8

Is Faslodex safe during pregnancy and breastfeeding?

Accepted Answer

Pregnancy

Faslodex can cause harm to a developing fetus. It is important to inform a healthcare provider if you are pregnant or planning to become pregnant before starting this medication.

Females who are able to become pregnant should have a pregnancy test to confirm they are not pregnant before starting treatment. Effective birth control should be used during treatment and for one year after the final dose. Males with female partners who can become pregnant should use effective contraception during treatment and for two years after the last dose.

Breastfeeding

It is not known if Faslodex passes into human breast milk. Due to the potential for serious side effects in a nursing infant, breastfeeding is not recommended during treatment and for one year after the last dose. Discuss feeding options with a healthcare provider if you are currently breastfeeding.

Question 9

What forms and strengths does Faslodex come in?

Accepted Answer

Available Forms

Faslodex is supplied as a sterile, clear, colorless to yellow, viscous liquid. It is intended for administration by a healthcare professional as an injection into the muscle.

The medication is provided in the following format:

Pre-filled Syringes: Single-dose glass syringes equipped with a safety needle.

Question 10

What is the FDA approval status of Faslodex?

Accepted Answer

FDA Approval Status

Faslodex (fulvestrant) was initially approved by the U.S. Food and Drug Administration (FDA) in 2002. It is classified as an estrogen receptor antagonist and is administered as an intramuscular injection.

Approved Indications

The FDA has approved Faslodex for the treatment of hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced or metastatic breast cancer in the following scenarios:

As a single agent for postmenopausal women who have not previously been treated with endocrine therapy.
As a single agent for postmenopausal women whose disease has progressed following other endocrine therapy.
In combination with palbociclib, abemaciclib, or ribociclib for women whose disease has progressed after endocrine therapy.
In combination with abemaciclib as an initial endocrine-based therapy for advanced or metastatic disease.

Regulatory Safety Information

There are currently no Boxed Warnings or Risk Evaluation and Mitigation Strategies (REMS) required by the FDA for Faslodex. However, regulatory labeling includes warnings regarding embryo-fetal toxicity, advising that the drug can cause harm to a developing fetus. It is also regulated with specific precautions for patients with moderate hepatic (liver) impairment, which may require dose adjustments.

Question 11

What should I know about Faslodex and cost?

Accepted Answer

Several factors can influence the total cost of treatment with Faslodex:

Insurance Coverage: Most insurance plans, including Medicare, typically cover Faslodex when it is prescribed for approved conditions. Out-of-pocket costs like copays or coinsurance will depend on the specific plan's benefits.
Generic Availability: Fulvestrant, the active ingredient in Faslodex, is available as a generic medication. Generic versions are generally less expensive than the brand-name drug.
Administration Fees: Because Faslodex is an intramuscular injection that must be administered by a healthcare professional, patients may be charged for the office visit or the medical procedure in addition to the cost of the medication itself.

Patients who are concerned about the cost of Faslodex may have options to reduce their expenses. Some pharmaceutical companies offer patient assistance programs or savings cards for those who qualify based on income or insurance status. It is often helpful to speak with a healthcare provider or a financial counselor at the treatment facility to explore available resources.

Faslodex

📋Overview

How It Works

Uses

Active Ingredients

Common Side Effects

Warnings & Precautions

Dosage

Pregnancy & Breastfeeding

Frequently Asked Questions

📚References

Found an Error?

Find Discounts for Faslodex

Hospitals.net Disclosure